NDC 73090-420

Sylvant

Siltuximab

Sylvant is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eusa Pharma (uk) Ltd. The primary component is Siltuximab.

Product ID73090-420_55f7afac-941e-48b7-8477-9478b550ad75
NDC73090-420
Product TypeHuman Prescription Drug
Proprietary NameSylvant
Generic NameSiltuximab
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-04-23
Marketing CategoryBLA / BLA
Application NumberBLA125496
Labeler NameEUSA Pharma (UK) Ltd
Substance NameSILTUXIMAB
Active Ingredient Strength100 mg/1
Pharm ClassesInterleukin-6 Antagonist [EPC], Interleukin-6 Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73090-420-01

1 VIAL, SINGLE-DOSE in 1 BOX (73090-420-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Marketing Start Date2014-04-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 73090-420-01 [73090042001]

Sylvant INJECTION, POWDER, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125496
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-04-23

Drug Details

Active Ingredients

IngredientStrength
SILTUXIMAB100 mg/1

OpenFDA Data

SPL SET ID:8d663642-f52e-49c0-a023-2da083fdfc0b
Manufacturer
UNII

Pharmacological Class

  • Interleukin-6 Antagonist [EPC]
  • Interleukin-6 Antagonists [MoA]

NDC Crossover Matching brand name "Sylvant" or generic name "Siltuximab"

NDCBrand NameGeneric Name
57894-420SYLVANTsiltuximab
57894-421SYLVANTsiltuximab
73090-420SylvantSiltuximab
73090-421SylvantSiltuximab

Trademark Results [Sylvant]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SYLVANT
SYLVANT
86975538 4657836 Live/Registered
JOHNSON & JOHNSON
2013-12-12
SYLVANT
SYLVANT
86142160 not registered Dead/Abandoned
JOHNSON & JOHNSON
2013-12-12
SYLVANT
SYLVANT
77887266 not registered Dead/Abandoned
JOHNSON & JOHNSON
2009-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.